SODIUM SULFACETAMIDE, SULFUR

N/A

Manufactured by Acella Pharmaceuticals, LLC

106 FDA adverse event reports analyzed

Last updated: 2026-04-15

About SODIUM SULFACETAMIDE, SULFUR

SODIUM SULFACETAMIDE, SULFUR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Acella Pharmaceuticals, LLC. The most commonly reported adverse reactions for SODIUM SULFACETAMIDE, SULFUR include ASTHMA, ERYTHEMA, HYPERSENSITIVITY, IMPAIRED QUALITY OF LIFE, INJECTION SITE PRURITUS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for SODIUM SULFACETAMIDE, SULFUR.

Top Adverse Reactions

ASTHMA2 reports
ERYTHEMA2 reports
HYPERSENSITIVITY2 reports
IMPAIRED QUALITY OF LIFE2 reports
INJECTION SITE PRURITUS2 reports
INJECTION SITE SWELLING2 reports
LETHARGY2 reports
NASOPHARYNGITIS2 reports
PAIN2 reports
PLATELET COUNT DECREASED2 reports
PRODUCT SUBSTITUTION ISSUE2 reports
SKIN IRRITATION2 reports
SOMNOLENCE2 reports
URTICARIA2 reports
WEIGHT INCREASED2 reports
ANXIETY1 reports
ARRHYTHMIA1 reports
ASTHENIA1 reports
BLADDER CYST1 reports
BLOOD URINE PRESENT1 reports
BURNING SENSATION1 reports
CANDIDA INFECTION1 reports
CHEMICAL INJURY1 reports
CONCUSSION1 reports
CONTUSION1 reports
COUGH1 reports
CYSTIC FIBROSIS1 reports
DERMATITIS CONTACT1 reports
DEVICE INFUSION ISSUE1 reports
DIARRHOEA1 reports
DRUG INEFFECTIVE1 reports
DRY SKIN1 reports
DYSPNOEA1 reports
EXERCISE TOLERANCE DECREASED1 reports
EXPOSURE TO TOXIC AGENT1 reports
EXTRASYSTOLES1 reports
EYE IRRITATION1 reports
FALL1 reports
FEELING HOT1 reports
FLUID RETENTION1 reports
FOOD REFUSAL1 reports
HALLUCINATION1 reports
HORDEOLUM1 reports
ILLNESS1 reports
IMPETIGO1 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION1 reports
INFLUENZA1 reports
INFUSION SITE BRUISING1 reports
INFUSION SITE ERYTHEMA1 reports
INJECTION SITE WARMTH1 reports
LIMB DISCOMFORT1 reports
LIQUID PRODUCT PHYSICAL ISSUE1 reports
LOSS OF CONSCIOUSNESS1 reports
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES1 reports
LOWER RESPIRATORY TRACT INFECTION1 reports
MALAISE1 reports
MULTIPLE ALLERGIES1 reports
MYDRIASIS1 reports
NAUSEA1 reports
NEPHROLITHIASIS1 reports
OEDEMA1 reports
OEDEMA PERIPHERAL1 reports
PALLOR1 reports
PERIPHERAL SWELLING1 reports
PRODUCT CONTAMINATION1 reports
PRODUCT DISTRIBUTION ISSUE1 reports
PRODUCT DOSE OMISSION ISSUE1 reports
PRODUCT PACKAGING QUANTITY ISSUE1 reports
PRODUCT PHYSICAL CONSISTENCY ISSUE1 reports
PRODUCT QUALITY ISSUE1 reports
PRODUCT USE IN UNAPPROVED INDICATION1 reports
PRURITUS1 reports
PSEUDOFOLLICULITIS1 reports
PYREXIA1 reports
QUALITY OF LIFE DECREASED1 reports
RESPIRATORY TRACT INFECTION1 reports
ROSACEA1 reports
SEASONAL ALLERGY1 reports
SINUSITIS1 reports
SKIN CANCER1 reports
SKIN DISORDER1 reports
SKIN HAEMORRHAGE1 reports
SKIN LACERATION1 reports
SLEEP APNOEA SYNDROME1 reports
SLEEP DISORDER1 reports
SOCIAL PROBLEM1 reports
STAPHYLOCOCCAL INFECTION1 reports
TACHYCARDIA1 reports
UPPER RESPIRATORY TRACT INFECTION1 reports
VACCINATION SITE VESICLES1 reports
VOMITING1 reports

Report Outcomes

Out of 19 classified reports for SODIUM SULFACETAMIDE, SULFUR:

Serious 52.6%Non-Serious 47.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male13 (65.0%)
Female7 (35.0%)

Reports by Age

Age 552 reports
Age 622 reports
Age 171 reports
Age 181 reports
Age 281 reports
Age 481 reports
Age 531 reports
Age 581 reports
Age 611 reports
Age 781 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with SODIUM SULFACETAMIDE, SULFUR?

This profile reflects 106 FDA FAERS reports that mention SODIUM SULFACETAMIDE, SULFUR. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for SODIUM SULFACETAMIDE, SULFUR?

Frequently reported terms in FAERS include ASTHMA, ERYTHEMA, HYPERSENSITIVITY, IMPAIRED QUALITY OF LIFE, INJECTION SITE PRURITUS, INJECTION SITE SWELLING. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures SODIUM SULFACETAMIDE, SULFUR?

Labeling and FAERS entries often list Acella Pharmaceuticals, LLC in connection with SODIUM SULFACETAMIDE, SULFUR. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.